Breast Cancer News and Research

Latest Breast Cancer News and Research

SyNAPSe® Trial by BHR Pharma deemed to have no safety issues according to DSMB

BHR Pharma, LLC announced today that the SyNAPSe® Trial's independent Data and Safety Monitoring Board (DSMB) evaluated safety data from 803 randomized patients and determined that no issues exist; therefore, the trial may continue towards its intended completion.

17 Jan 2013

US breast reconstruction trends highlighted

The number of women undergoing breast reconstruction immediately after mastectomy has increased in recent years in the USA, with implant use being the most common approach, research shows.

17 Jan 2013

Study identifies subgroups of patients with distinct, persistent pain after breast cancer surgery

Some 25 percent of breast cancer surgery patients experience significant, persistent pain six months after the procedure, and new research published in The Journal of Pain showed that women with preoperative breast pain have the highest risk for extended post-surgical pain.

17 Jan 2013

SF3B1 gene mutations in uveal melanoma linked to favorable features

Melanomas that develop in the eye often are fatal. Now, scientists at Washington University School of Medicine in St. Louis report they have identified a mutated gene in melanoma tumors of the eye that appears to predict a good outcome.

17 Jan 2013

Boehringer Ingelheim receives FDA Priority Review for afatinib to treat EGFR mutation-positive NSCLC

Boehringer Ingelheim today announced that the New Drug Application (NDA) for its investigational oncology compound afatinib has been accepted for filing and granted Priority Review by the U.S. Food and Drug Administration (FDA).

17 Jan 2013

State roundup: Texas, Ga. companies forming ACOs

College student Emily Howell depended on her local Planned Parenthood clinic. Now, she and nearly 50,000 other Texas women will have to find a new place to get free breast cancer screenings, pap smears and birth control.

16 Jan 2013

Tamoxifen can counteract some pathologic features in mouse model of DMD

A new study has found that tamoxifen, a well-known breast cancer drug, can counteract some pathologic features in a mouse model of Duchenne muscular dystrophy (DMD). At present, no treatment is known to produce long-term improvement of the symptoms in boys with DMD, a debilitating muscular disorder that is characterized by progressive muscle wasting, respiratory and cardiac impairments, paralysis, and premature death.

16 Jan 2013

NEDD9 gene controls growth of progenitor cells that give rise to breast tumors

Breast cancer is the second leading cause of cancer deaths among women in the United States. Many of these deaths occur when there is an initial diagnosis of invasive or metastatic disease. A protein called NEDD9-which regulates cell migration, division and survival-has been linked to tumor invasion and metastasis in a variety of cancers.

16 Jan 2013

Fox Chase's OHCHD to fund community-based patient navigation services

Fox Chase Cancer Center's Office of Health Communications and Health Disparities (OHCHD) recently received a grant from the National Breast Cancer Foundation to fund community-based patient navigation services.

16 Jan 2013

Aggressive breast cancer’s metastasis molecular switch identified

Scientists at Weill Cornell Medical College have discovered the molecular switch that allows aggressive triple negative breast cancer cells to grow the amoeba-like protrusions they need to crawl away from a primary tumor and metastasize throughout the body. Their findings, published in Cancer Cell, suggest a novel approach for developing agents to treat cancer once it has spread.

15 Jan 2013

Research roundup: Effectiveness of mobile clinics; Can more alternative medicine coverage save money?

Approximately 2,000 mobile health clinics in the U.S. have 6.5 million patient visits annually. Researchers analyzed data from nearly 6,000 patients from 2010 to 2012 from one program, to examine the clinical impact and cost-effectiveness.

15 Jan 2013

DESI technique identifies cancer type, grade and tumor margins in brain surgery patients

A new tool that could allow for faster, more comprehensive testing of brain tissue during surgery successfully identified the cancer type, grade and tumor margins in five brain surgery patients, according to a Purdue University and Brigham and Women's Hospital study.

11 Jan 2013

Longer looks: A key Hagel mission is to cut military health costs; Medical lessons from a mother's death; How they price - and how we pay for -a $300,000 medicine

As David Brooks and Paul Wolfowitz and many others have shown, it's easy to frame our messy fiscal conundrum in these simple terms of guns vs. butter, or rather, guns vs grandma's buttery-yellow, super-pricey heart medication.

11 Jan 2013

Medicare spends about as much screening for breast cancer as treating it -- $1B annually

Medicare spends $1 billion annually on breast cancer screening, a new study has found. Another report, this one from UnitedHealth, says changes to how the government coordinates patient care could save half a trillion dollars over a decade.

11 Jan 2013

TapImmune announces results from HER2/neu interim study on breast cancer

TapImmune Inc. has announced that an interim safety analysis on the first five breast cancer patients treated with HER2/neu Class II antigens at Mayo Clinic, Rochester, MN., did not show any serious adverse events.

11 Jan 2013

UCSF Helen Diller Family Comprehensive Cancer Center receives $36M NCI grant

The National Cancer Institute has awarded the UCSF Helen Diller Family Comprehensive Cancer Center a $36 million grant to fund cutting edge research programs and clinical trials over five years.

10 Jan 2013

VolitionRx to commence large internal clinical study for Nucleosomics diagnostic products

VolitionRx Limited, a life sciences company focused on developing blood-based diagnostic tests, announces that it will commence a large internal clinical study for its Nucleosomics diagnostic products this month.

9 Jan 2013

Moffitt Cancer Center initiates PV-10 Phase 1 study in melanoma

Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, reports that the Moffitt Cancer Center has initiated a Phase 1 study to investigate potential immune biomarkers in both tumor tissue and peripheral blood after intralesional PV-10 injection of melanoma tumors.

9 Jan 2013

Kingston University professor receives prestigious prize for work on drug metabolism

The Dean of the Faculty of Science, Engineering and Computing at London's Kingston University has received a prestigious prize recognising her lifetime's work on drug metabolism.

9 Jan 2013

Overall cancer death rates continue to decline in the U.S.: Report

The Annual Report to the Nation on the Status of Cancer, 1975-2009, shows that overall cancer death rates continued to decline in the United States among both men and women, among all major racial and ethnic groups, and for all of the most common cancer sites, including lung, colon and rectum, female breast, and prostate.

9 Jan 2013

Breast Cancer News and Research

Latest Breast Cancer News and Research

SyNAPSe® Trial by BHR Pharma deemed to have no safety issues according to DSMB

US breast reconstruction trends highlighted

Study identifies subgroups of patients with distinct, persistent pain after breast cancer surgery

SF3B1 gene mutations in uveal melanoma linked to favorable features

Boehringer Ingelheim receives FDA Priority Review for afatinib to treat EGFR mutation-positive NSCLC

State roundup: Texas, Ga. companies forming ACOs

Tamoxifen can counteract some pathologic features in mouse model of DMD

NEDD9 gene controls growth of progenitor cells that give rise to breast tumors

Fox Chase's OHCHD to fund community-based patient navigation services

Aggressive breast cancer’s metastasis molecular switch identified

Research roundup: Effectiveness of mobile clinics; Can more alternative medicine coverage save money?

DESI technique identifies cancer type, grade and tumor margins in brain surgery patients

Longer looks: A key Hagel mission is to cut military health costs; Medical lessons from a mother's death; How they price - and how we pay for -a $300,000 medicine

Medicare spends about as much screening for breast cancer as treating it -- $1B annually

TapImmune announces results from HER2/neu interim study on breast cancer

UCSF Helen Diller Family Comprehensive Cancer Center receives $36M NCI grant

VolitionRx to commence large internal clinical study for Nucleosomics diagnostic products

Moffitt Cancer Center initiates PV-10 Phase 1 study in melanoma

Kingston University professor receives prestigious prize for work on drug metabolism

Overall cancer death rates continue to decline in the U.S.: Report

How does norepinephrine influence anxiety-related behaviours?

Transforming Lab Workflows with Cell Culture Automation

Building Bridges to Scalable Allogeneic Cell Therapy

Breast Cancer News and Research

Latest Breast Cancer News and Research

How does norepinephrine influence anxiety-related behaviours?

Transforming Lab Workflows with Cell Culture Automation

Building Bridges to Scalable Allogeneic Cell Therapy

Newsletters you may be interested in